90 related articles for article (PubMed ID: 11996001)
1. Computer modeling studies of the structural role of NADPH binding to active site mutants of human dihydrofolate reductase in complex with piritrexim.
Nowak W; Cody V; Wojtczak A
Acta Biochim Pol; 2001; 48(4):903-16. PubMed ID: 11996001
[TBL] [Abstract][Full Text] [Related]
2. Structural analysis of Pneumocystis carinii and human DHFR complexes with NADPH and a series of five potent 6-[5'-(ω-carboxyalkoxy)benzyl]pyrido[2,3-d]pyrimidine derivatives.
Cody V; Pace J
Acta Crystallogr D Biol Crystallogr; 2011 Jan; 67(Pt 1):1-7. PubMed ID: 21206056
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity correlations for three pyrido[2,3-d]pyrimidine antifolates binding to human and Pneumocystis carinii dihydrofolate reductase.
Cody V; Pace J; Namjoshi OA; Gangjee A
Acta Crystallogr F Struct Biol Commun; 2015 Jun; 71(Pt 6):799-803. PubMed ID: 26057816
[TBL] [Abstract][Full Text] [Related]
4. Detection of long-lived bound water molecules in complexes of human dihydrofolate reductase with methotrexate and NADPH.
Meiering EM; Wagner G
J Mol Biol; 1995 Mar; 247(2):294-308. PubMed ID: 7707376
[TBL] [Abstract][Full Text] [Related]
5. Defining the binding site of homotetrameric R67 dihydrofolate reductase and correlating binding enthalpy with catalysis.
Strader MB; Chopra S; Jackson M; Smiley RD; Stinnett L; Wu J; Howell EE
Biochemistry; 2004 Jun; 43(23):7403-12. PubMed ID: 15182183
[TBL] [Abstract][Full Text] [Related]
6. Understanding the role of Leu22 variants in methotrexate resistance: comparison of wild-type and Leu22Arg variant mouse and human dihydrofolate reductase ternary crystal complexes with methotrexate and NADPH.
Cody V; Luft JR; Pangborn W
Acta Crystallogr D Biol Crystallogr; 2005 Feb; 61(Pt 2):147-55. PubMed ID: 15681865
[TBL] [Abstract][Full Text] [Related]
7. Structural variations of piritrexim, a lipophilic inhibitor of human dihydrofolate reductase: synthesis, antitumor activity and molecular modeling investigations.
Zink M; Lanig H; Troschütz R
Eur J Med Chem; 2004 Dec; 39(12):1079-88. PubMed ID: 15571870
[TBL] [Abstract][Full Text] [Related]
8. Structural comparison of chromosomal and exogenous dihydrofolate reductase from Staphylococcus aureus in complex with the potent inhibitor trimethoprim.
Heaslet H; Harris M; Fahnoe K; Sarver R; Putz H; Chang J; Subramanyam C; Barreiro G; Miller JR
Proteins; 2009 Aug; 76(3):706-17. PubMed ID: 19280600
[TBL] [Abstract][Full Text] [Related]
9. Changes in the electron density of the cofactor NADPH on binding to E. coli dihydrofolate reductase.
Bajorath J; Li ZQ; Fitzgerald G; Kitson DH; Farnum M; Fine RM; Kraut J; Hagler AT
Proteins; 1991; 11(4):263-270. PubMed ID: 1758881
[TBL] [Abstract][Full Text] [Related]
10. NMR solution structure of the antitumor compound PT523 and NADPH in the ternary complex with human dihydrofolate reductase.
Johnson JM; Meiering EM; Wright JE; Pardo J; Rosowsky A; Wagner G
Biochemistry; 1997 Apr; 36(15):4399-411. PubMed ID: 9109647
[TBL] [Abstract][Full Text] [Related]
11. Structure-based design and synthesis of lipophilic 2,4-diamino-6-substituted quinazolines and their evaluation as inhibitors of dihydrofolate reductases and potential antitumor agents.
Gangjee A; Vidwans AP; Vasudevan A; Queener SF; Kisliuk RL; Cody V; Li R; Galitsky N; Luft JR; Pangborn W
J Med Chem; 1998 Aug; 41(18):3426-34. PubMed ID: 9719595
[TBL] [Abstract][Full Text] [Related]
12. Preferential selection of isomer binding from chiral mixtures: alternate binding modes observed for the E and Z isomers of a series of 5-substituted 2,4-diaminofuro[2,3-d]pyrimidines as ternary complexes with NADPH and human dihydrofolate reductase.
Cody V; Piraino J; Pace J; Li W; Gangjee A
Acta Crystallogr D Biol Crystallogr; 2010 Dec; 66(Pt 12):1271-7. PubMed ID: 21123866
[TBL] [Abstract][Full Text] [Related]
13. Unusual binding stoichiometries and cooperativity are observed during binary and ternary complex formation in the single active pore of R67 dihydrofolate reductase, a D2 symmetric protein.
Bradrick TD; Beechem JM; Howell EE
Biochemistry; 1996 Sep; 35(35):11414-24. PubMed ID: 8784197
[TBL] [Abstract][Full Text] [Related]
14. Comparison of ternary crystal complexes of F31 variants of human dihydrofolate reductase with NADPH and a classical antitumor furopyrimidine.
Cody V; Galitsky N; Luft JR; Pangborn W; Blakley RL; Gangjee A
Anticancer Drug Des; 1998 Jun; 13(4):307-15. PubMed ID: 9627670
[TBL] [Abstract][Full Text] [Related]
15. Ligand-induced conformational changes in the crystal structures of Pneumocystis carinii dihydrofolate reductase complexes with folate and NADP+.
Cody V; Galitsky N; Rak D; Luft JR; Pangborn W; Queener SF
Biochemistry; 1999 Apr; 38(14):4303-12. PubMed ID: 10194348
[TBL] [Abstract][Full Text] [Related]
16. New 2,4-diamino-5-(2',5'-substituted benzyl)pyrimidines as potential drugs against opportunistic infections of AIDS and other immune disorders. Synthesis and species-dependent antifolate activity.
Rosowsky A; Forsch RA; Sibley CH; Inderlied CB; Queener SF
J Med Chem; 2004 Mar; 47(6):1475-86. PubMed ID: 14998335
[TBL] [Abstract][Full Text] [Related]
17. Breaking symmetry: mutations engineered into R67 dihydrofolate reductase, a D2 symmetric homotetramer possessing a single active site pore.
Smiley RD; Stinnett LG; Saxton AM; Howell EE
Biochemistry; 2002 Dec; 41(52):15664-75. PubMed ID: 12501195
[TBL] [Abstract][Full Text] [Related]
18. Three-dimensional structure of M. tuberculosis dihydrofolate reductase reveals opportunities for the design of novel tuberculosis drugs.
Li R; Sirawaraporn R; Chitnumsub P; Sirawaraporn W; Wooden J; Athappilly F; Turley S; Hol WG
J Mol Biol; 2000 Jan; 295(2):307-23. PubMed ID: 10623528
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory properties and X-ray crystallographic study of the binding of AR-101, AR-102 and iclaprim in ternary complexes with NADPH and dihydrofolate reductase from Staphylococcus aureus.
Oefner C; Parisi S; Schulz H; Lociuro S; Dale GE
Acta Crystallogr D Biol Crystallogr; 2009 Aug; 65(Pt 8):751-7. PubMed ID: 19622858
[TBL] [Abstract][Full Text] [Related]
20. Role of ionic interactions in ligand binding and catalysis of R67 dihydrofolate reductase.
Hicks SN; Smiley RD; Hamilton JB; Howell EE
Biochemistry; 2003 Sep; 42(36):10569-78. PubMed ID: 12962480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
